Coronavirus update for Friday, May 15 as of 2:30 p.m.

Centers for Medicare & Medicaid Services


Department of Health and Human Services

HHS and its Agency for Healthcare Research and Quality (AHRQ) will award $5 million in fiscal year 2020 to support novel, high-impact studies that evaluate the responsiveness of health care delivery systems, health care professionals, and the overall U.S. health care system to the COVID-19 pandemic.   See HHS’s announcement of the grant program here and find the full funding announcement here.

Centers for Disease Control and Prevention

The CDC issued a health advisory through its health alert network with background information on several cases of a recently reported multi-system inflammatory syndrome in children (MIS-C) associated with COVID-19.  The advisory includes a case definition for this syndrome and the CDC’s recommendation that providers report any patient who meets the case definition to local, state, and territorial health departments to enhance knowledge of risk factors, pathogenesis, clinical course, and treatment of this syndrome.

Food and Drug Administration

  • The FDA issued an update to its guidance for pharmacy compounders that experience shortages of the personal protective equipment they typically use to compound human drugs that are intended or expected to be sterile.  In the update, FDA clarifies that drugs can be compounded under the policy in a segregated compounding area that is not in a cleanroom when specific beyond-use dates are used.


Federal Funding Opportunities for Hospitals

The National Alliance of Safety-Net Hospitals has prepared a document that collects and presents in one place the various new federal funding opportunities for hospitals resulting from legislation addressing the COVID-19 public health emergency.  Find that document here.